The role of miRNAs in the development of cholangiopathies. Part 2
The role of miRNA in the development of cholangiopathies is considered in the scientific review. This article discusses the role of miRNA in biliary atresia, polycystic liver disease, and cholangiocarcinoma. To write the article, information was searched using Scopus, Web of Science, MedLine, PubMe...
| Published in: | Zdorovʹe Rebenka |
|---|---|
| Main Authors: | A.E. Abaturov, V.L. Babуch |
| Format: | Article |
| Language: | English |
| Published: |
Zaslavsky O.Yu.
2023-09-01
|
| Subjects: | |
| Online Access: | https://childshealth.zaslavsky.com.ua/index.php/journal/article/view/1619 |
Similar Items
The role of miRNAs in the development of cholangiopathies. Part 2
by: A.E. Abaturov, et al.
Published: (2023-09-01)
by: A.E. Abaturov, et al.
Published: (2023-09-01)
The role of miRNAs in the development of cholangiopathies. Part 1
by: A.E. Abaturov, et al.
Published: (2023-06-01)
by: A.E. Abaturov, et al.
Published: (2023-06-01)
Regulation of miRNA content. Part 1. Editing miRNA. Тailing miRNA
by: A.E. Abaturov, et al.
Published: (2021-06-01)
by: A.E. Abaturov, et al.
Published: (2021-06-01)
Mechanisms of action of extracellular miRNAs
by: A.E. Abaturov, et al.
Published: (2022-12-01)
by: A.E. Abaturov, et al.
Published: (2022-12-01)
The role of miRNAs in the development of hepatobiliary diseases
by: O.E. Abaturov, et al.
Published: (2023-03-01)
by: O.E. Abaturov, et al.
Published: (2023-03-01)
The role of microRNA in the development of liver diseases. Part 2
by: A.E. Abaturov, et al.
Published: (2023-05-01)
by: A.E. Abaturov, et al.
Published: (2023-05-01)
Mechanisms of action of cytoplasmic microRNAs. Part 2. MicroRNA-mediated post-translational silencing
by: A.E. Abaturov, et al.
Published: (2022-05-01)
by: A.E. Abaturov, et al.
Published: (2022-05-01)
Mechanisms of action of intranuclear microRNAs. Part 1. Influence of microRNA on transcription
by: A.E. Abaturov, et al.
Published: (2021-12-01)
by: A.E. Abaturov, et al.
Published: (2021-12-01)
Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets
by: Alina Grama, et al.
Published: (2023-10-01)
by: Alina Grama, et al.
Published: (2023-10-01)
The role of microRNA in the development of liver diseases. Part 1
by: A.E. Abaturov, et al.
Published: (2023-04-01)
by: A.E. Abaturov, et al.
Published: (2023-04-01)
Mechanisms of action of cytoplasmic miRNAs. Part 4. Recruitment of the DCP1-DCP2 decapping complex. Mechanisms of final mRNA degradation
by: A.E. Abaturov, et al.
Published: (2022-09-01)
by: A.E. Abaturov, et al.
Published: (2022-09-01)
Mechanisms of action of cytoplasmic microRNAs. Part 3. TNRC6-associated mechanism of miRNA-mediated mRNA degradation
by: A.E. Abaturov, et al.
Published: (2022-06-01)
by: A.E. Abaturov, et al.
Published: (2022-06-01)
Mechanisms of action of cytoplasmic microRNAs. Part 5. MicroRNA-mediated silencing caused during translation initiation and post-initiation
by: A.E. Abaturov, et al.
Published: (2022-10-01)
by: A.E. Abaturov, et al.
Published: (2022-10-01)
Regulation of microRNA with food. Part 1. Food of plant origin
by: A.E. Abaturov, et al.
Published: (2023-10-01)
by: A.E. Abaturov, et al.
Published: (2023-10-01)
Regulation of microRNA with food. Part 2. Food of animal origin
by: A.E. Abaturov, et al.
Published: (2023-11-01)
by: A.E. Abaturov, et al.
Published: (2023-11-01)
AIDS Cholangiopathy – Diagnostic imaging features
by: Vandana V Ahluwalia, et al.
Published: (2017-01-01)
by: Vandana V Ahluwalia, et al.
Published: (2017-01-01)
An Unusual Cause of Cholestasis in an Infant: Biliary Atresia Type IIB
by: Poonam Sherwani, et al.
Published: (2021-07-01)
by: Poonam Sherwani, et al.
Published: (2021-07-01)
Drug regulation of microRNA
by: A.E. Abaturov, et al.
Published: (2023-12-01)
by: A.E. Abaturov, et al.
Published: (2023-12-01)
Primary Cilia, Hypoxia, and Liver Dysfunction: A New Perspective on Biliary Atresia
by: Patrícia Quelhas, et al.
Published: (2025-04-01)
by: Patrícia Quelhas, et al.
Published: (2025-04-01)
Ear atresia: Is there a role of apoptosis-regulating miRNAs?
by: Ezgi Aslan, et al.
Published: (2018-09-01)
by: Ezgi Aslan, et al.
Published: (2018-09-01)
The use of fully covered self-expandable metal stents in the endoscopic treatment of portal cavernoma cholangiopathy
by: Abdullah Murat Buyruk, et al.
Published: (2023-11-01)
by: Abdullah Murat Buyruk, et al.
Published: (2023-11-01)
AUTOIMMUNE PANCREATITIS AND IGG4-ASSOCIATED CHOLANGIOPATHIES (review)
by: Yu. S. Kokarev
Published: (2018-05-01)
by: Yu. S. Kokarev
Published: (2018-05-01)
COVID-Associated Cast-Forming Cholangiopathy: A Commentary on Disease Mechanism, Treatment, and Prognosis
by: Sarkis Y, et al.
Published: (2023-03-01)
by: Sarkis Y, et al.
Published: (2023-03-01)
The Crucial Role of Cholangiocytes in Cholangiopathies
Published: (2012-07-01)
Published: (2012-07-01)
The world of microRNAs of the hepatobiliary system
by: A.E. Abaturov, et al.
Published: (2021-03-01)
by: A.E. Abaturov, et al.
Published: (2021-03-01)
MiRNA-29b accelerates the PDGF in exosomes and stimulates hepatic stellate cells to promote liver fibrosis in biliary atresia
by: Xilin Liao, et al.
Published: (2025-07-01)
by: Xilin Liao, et al.
Published: (2025-07-01)
COVID-19-Related Cholangiopathy: Histological Findings
by: Valéria F. A. Borges, et al.
Published: (2024-08-01)
by: Valéria F. A. Borges, et al.
Published: (2024-08-01)
IgG4-Associated Cholangitis Can Mimic Hilar Cholangiocarcinoma
Published: (2015-07-01)
Published: (2015-07-01)
Reversine attenuates cholestatic ductular reaction in rats
by: Di Huang, et al.
Published: (2023-05-01)
by: Di Huang, et al.
Published: (2023-05-01)
Relationship between the expression level of microRNA and the features of clinical course of the gallbladder and Оddi's sphincter functional disorders in children
by: O. Ye. Abaturov, et al.
Published: (2019-10-01)
by: O. Ye. Abaturov, et al.
Published: (2019-10-01)
Correctable biliary atresia and cholangiocarcinoma: a case report of a 63-year-old patient
by: Masaki Nio, et al.
Published: (2019-11-01)
by: Masaki Nio, et al.
Published: (2019-11-01)
Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
by: Zhao Jinyu, et al.
Published: (2024-08-01)
by: Zhao Jinyu, et al.
Published: (2024-08-01)
Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
by: Ji-Won Park, et al.
Published: (2022-05-01)
by: Ji-Won Park, et al.
Published: (2022-05-01)
Features of biliary tract diseases in ketamine abusers: a systematic review of case reports
by: Alireza Teymouri, et al.
Published: (2024-03-01)
by: Alireza Teymouri, et al.
Published: (2024-03-01)
Clinical and Histopathological Discoveries in Patients with Hepatic Injury and Cholangiopathy Who Have Died of COVID-19: Insights and Opportunities for Intervention
by: Lim JK, et al.
Published: (2023-10-01)
by: Lim JK, et al.
Published: (2023-10-01)
Current Knowledge of MicroRNAs (miRNAs) in Acute Coronary Syndrome (ACS): ST-Elevation Myocardial Infarction (STEMI)
by: Daniela Maria Tanase, et al.
Published: (2021-10-01)
by: Daniela Maria Tanase, et al.
Published: (2021-10-01)
Pathology of Cholangiocarcinomas
by: Nathalie Guedj
Published: (2022-12-01)
by: Nathalie Guedj
Published: (2022-12-01)
Bilirubin Levels at 1st and 3rd Postoperative Months are Significant in Determining the Success of the Kasai Portoenterostomy
by: Ülgen Çeltik, et al.
Published: (2021-09-01)
by: Ülgen Çeltik, et al.
Published: (2021-09-01)
Cellular miRNAs and viruses: trends in miRNA sequestering and target de-repression
by: Bonita H. Powell, et al.
Published: (2025-07-01)
by: Bonita H. Powell, et al.
Published: (2025-07-01)
Number of cholangitis episodes as a prognostic marker to predict timing of liver transplantation in biliary atresia patients after Kasai portoenterostomy
by: Szu-Ying Chen, et al.
Published: (2018-04-01)
by: Szu-Ying Chen, et al.
Published: (2018-04-01)
Similar Items
-
The role of miRNAs in the development of cholangiopathies. Part 2
by: A.E. Abaturov, et al.
Published: (2023-09-01) -
The role of miRNAs in the development of cholangiopathies. Part 1
by: A.E. Abaturov, et al.
Published: (2023-06-01) -
Regulation of miRNA content. Part 1. Editing miRNA. Тailing miRNA
by: A.E. Abaturov, et al.
Published: (2021-06-01) -
Mechanisms of action of extracellular miRNAs
by: A.E. Abaturov, et al.
Published: (2022-12-01) -
The role of miRNAs in the development of hepatobiliary diseases
by: O.E. Abaturov, et al.
Published: (2023-03-01)
